Zobrazeno 1 - 10
of 184
pro vyhledávání: '"S. Morecki"'
Publikováno v:
Molecular Biotechnology. 11:181-194
Soybean agglutin (SBA) is a plant lectin that has been used to fractionate bone marrow cells. It binds bone marrow mononuclear cells, including mature myeloid, erythroid, and lymphoid cells, but has very low binding affinity and no toxic effect to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5d5b083270d91e3c34ab8a7823a3aeb
https://doi.org/10.1007/bf02915811
https://doi.org/10.1007/bf02915811
Publikováno v:
International Journal of Cancer. 75:894-899
Indomethacin, an inhibitor of cyclo-oxygenase given orally, reduced the tumorigenicity of cancer cells in a non-immunogenic murine model of mammary adenocarcinoma (4T1). In the presence of indomethacin, a dose-dependent immune protection could be ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acec4cc06ef9c87d7e229cb01316e309
https://doi.org/10.1002/(sici)1097-0215(19980316)75:6<894::aid-ijc12>3.0.co
https://doi.org/10.1002/(sici)1097-0215(19980316)75:6<894::aid-ijc12>3.0.co
Publikováno v:
Methods in molecular medicine. 9
Soybean agglutinin (SBA) is a plant lectin, a glycoprotein of nonimmune origin that binds specifically to cell surface carbohydrates through noncovalent combinations and thus provokes agglutination of the bound cells. SBA has been used, therefore, to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::701c27c4d89f4a0376438a8053a3a3b9
https://pubmed.ncbi.nlm.nih.gov/21374473
https://pubmed.ncbi.nlm.nih.gov/21374473
Publikováno v:
Cancer research. 58(17)
The effect of allogeneic cell therapy on tumor growth was studied in a murine model of mammary carcinoma (4T1) as an experimental model of solid tumors in humans. i.v. inoculation of 4T1 (H-2d) cells into syngeneic mice [BALB/c or (BALB/cXC57BL/6)F1]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c33aef433d0859d65bad66a563ef0328
https://pubmed.ncbi.nlm.nih.gov/9731499
https://pubmed.ncbi.nlm.nih.gov/9731499
Publikováno v:
Cytokines, cellularmolecular therapy. 4(2)
The effect of cytokine transduction on the tumorigenicity and immunogenicity of murine non-immunogeneic mammary carcinoma (4T1), acute myeloid leukemia (mAML) and partially immunogenic B-cell leukemia (BCL1) has been evaluated in syngeneic strains of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::38afae35903e00167ff686fc3195132c
https://pubmed.ncbi.nlm.nih.gov/9681247
https://pubmed.ncbi.nlm.nih.gov/9681247
Publikováno v:
International journal of cancer. 75(6)
Indomethacin, an inhibitor of cyclo-oxygenase given orally, reduced the tumorigenicity of cancer cells in a non-immunogenic murine model of mammary adenocarcinoma (4T1). In the presence of indomethacin, a dose-dependent immune protection could be ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::47c12048257896fe6657bdd4aabbe3cc
https://pubmed.ncbi.nlm.nih.gov/9506535
https://pubmed.ncbi.nlm.nih.gov/9506535
Autor:
J, Kapelushnik, A, Nagler, R, Or, E, Naparstek, A, Ackerstein, S, Samuel, S, Morecki, C, Nabet, S, Slavin
Publikováno v:
Bone marrow transplantation. 18(6)
We describe a 17-year-old male patient with chronic myelogenous leukemia (CML) in hematologic and cytogenetic relapse 4 months post-non-T cell-depleted allogeneic bone marrow transplantation for accelerated CML. Two sequential buffy coat transfusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5b50679e0e3bd0cf0ef5c2be35fc809
https://pubmed.ncbi.nlm.nih.gov/8971387
https://pubmed.ncbi.nlm.nih.gov/8971387
Publikováno v:
Lymphokine and cytokine research. 12(3)
Efforts were directed to achieve an increased lymphokine-activated non-MHC-restricted killing (LAK) activity greater than that induced by rIL-2 alone. Human peripheral blood (PB) and bone marrow (BM)-derived mononuclear cells (MC) were exposed in vit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1afbd8648556aa459e34caaa0fde23fc
https://pubmed.ncbi.nlm.nih.gov/8347764
https://pubmed.ncbi.nlm.nih.gov/8347764
Autor:
S, Slavin, L, Weiss, A, Ackerstein, U, Vourka-Karussis, S, Morecki, R, Or, A, Nagler, J, Kapelushnik, M, Delukina, P, Drakos
Publikováno v:
Bone marrow transplantation. 12
High, myeloablative doses of chemoradiotherapy represent the treatment of choice for a large number of malignant hematological diseases that cannot be successfully treated with conventional chemotherapy. Residual tumor cells following high dose chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a49f47c65a70b6a49cffd9c45487a3a
https://pubmed.ncbi.nlm.nih.gov/8124259
https://pubmed.ncbi.nlm.nih.gov/8124259
Publikováno v:
Bone marrow transplantation. 7(4)
The effect of immunocompetent lymphocyte depletion on precursors and effector cells of IL2 activated non-MHC restricted cytotoxic cells (LAK) generated from bone marrow (BM) or peripheral blood was investigated. Lymphocyte depletion was carried out b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14afd45d7253eb4b224de62b2b8b7bed
https://pubmed.ncbi.nlm.nih.gov/2070132
https://pubmed.ncbi.nlm.nih.gov/2070132